MSOS Stock analysis & Cannabis stocks – How I am trading now

It’s a rar­i­ty these days to see the top phar­ma in­dus­try lob­by­ing group join Sen­ate and House De­mo­c­rat lead­ers and ar­gue the same side of

The FDA is de­fend­ing its in­creased use of non-bind­ing guid­ance doc­u­ments rather than legal­ly-en­force­able rule­mak­ings, ar­gu­ing that guid­ance can bet­ter keep pace with the lat­est